Smith+Nephew Turns Corner in Ortho Recovery

Smith+Nephew reported 2Q25 orthopedic sales of $1 billion, up 6.4% compared to the second quarter of 2024. For the first half of 2025, the company generated $2 billion in orthopedic sales, up 3.8% compared to the prior period.

The company appears to be back on track, as it is steadily improving its orthopedic performance and has weathered...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0